CLINICAL CHARACTERISTICS OF PATIENTS WITH PSORIASIS AND ATOPIC DERMATITIS IN VIETNAM
Main Article Content
Abstract
Background: Dyslipidemia is increasingly recognized in psoriasis and atopic dermatitis due to systemic inflammation and cardiovascular risks. However, differences in lipid profiles between the two diseases remain inconsistent in previous reports. Objective: To compare serum lipid characteristics between patients with psoriasis and atopic dermatitis. Materials and Methods: A cross-sectional study was conducted at Ho Chi Minh City Dermatology Hospital from February to October 2025. Total cholesterol and high-density lipoprotein (HDL) levels were collected and statistically compared between groups. Results: Dyslipidemia was observed in both groups. Total cholesterol levels did not differ significantly between psoriasis and atopic dermatitis (p>0.05). In contrast, HDL levels were significantly lower in the atopic dermatitis group (p<0.001), indicating more prominent lipid metabolic alterations. The proportions of elevated total cholesterol and reduced HDL did not show significant differences. Conclusion: Dyslipidemia is present in both chronic inflammatory skin diseases. HDL appears to be a more sensitive clinical indicator than total cholesterol in differentiating metabolic disturbances. Monitoring cardiovascular risk may be particularly relevant in patients with atopic dermatitis.
Article Details
Keywords
psoriasis; atopic dermatitis; dyslipidemia; total cholesterol; HDL
References
2. Orlando, G., et al., Psoriasis and cardiovascular diseases: an immune-mediated cross talk? Frontiers in Immunology, 2022. 13: p. 868277.
3. Itamura, M. and Y. Sawada, Involvement of atopic dermatitis in the development of systemic inflammatory diseases. International journal of molecular sciences, 2022. 23(21): p. 13445.
4. Nakhwa, Y., R. Rashmi, and K. Basavaraj, Dyslipidemia in psoriasis: a case controlled study. International scholarly research notices, 2014. 2014(1): p. 729157.
5. Pietrzak, A., et al., Psoriasis and serum lipid abnormalities. Dermatologic Therapy, 2010. 23(2).
6. Pietrzak, A., et al., Serum lipid metabolism in psoriasis and psoriatic arthritis–an update. Archives of medical science, 2019. 15(2): p. 369-375.
7. Richard, M.-A., et al. Prevalence of comorbidities in atopic dermatitis and psoriasis in the French population. in Annales de dermatologie et de venereologie. 2021. Elsevier.
8. Masson, W., M. Lobo, and G. Molinero, Psoriasis and cardiovascular risk: a comprehensive review. Advances in therapy, 2020. 37(5): p. 2017-2033.